Pacific Biosciences controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2019
PGI files patent infringement complaint against PacBio
Lawsuit filed
Personal Genomics Taiwan, Inc. (PGI) filed a complaint against Pacific Biosciences of California, Inc. (PacBio) in U.S. District Court. The complaint alleged that PacBio's Sequel and Sequel II products and related commercialization activities infringe claims of PGI's U.S. Patent No. 7,767,441. The filing is recorded as a patent infringement dispute between the two companies.
Source excerpt
Personal Genomics Taiwan, Inc. ("PGI"), today announced that it has filed a complaint in the U.S. District Court for the District of Delaware against Pacific Biosciences of California, Inc. ("PacBio"). The complaint asserts that PacBio's Sequel and Sequel II, as well as related commercialization activities by PacBio, infringe one or more claims of U.S. Patent No. 7,767,441 (the "'441 patent"), owned by PGI.